XML 62 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidated Statements Of Cash Flows - USD ($)
shares in Millions, $ in Millions
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Cash flows from operating activities:    
Net earnings $ 653.1 $ 742.6
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 691.4 398.1
Share-based compensation expense 66.4 48.0
Change in estimated sales allowances 399.8 462.0
Deferred income tax provision (62.2) (250.5)
Loss from equity method investments 77.5 65.5
Other non-cash items 206.2 120.3
Litigation settlements, net 19.1 47.2
Changes in operating assets and liabilities:    
Accounts receivable (454.1) (339.2)
Inventories (288.4) (163.4)
Trade accounts payable 242.5 (126.8)
Income taxes (178.5) 30.4
Other operating assets and liabilities, net (16.3) (146.0)
Net cash provided by operating activities 1,356.5 888.2
Cash flows from investing activities:    
Capital expenditures (207.3) (220.3)
Cash paid for acquisitions, net 0.0 (50.0)
Proceeds from sale of property, plant and equipment 2.3 8.8
Purchase of marketable securities (59.1) (17.6)
Proceeds from sale of marketable securities 29.4 16.4
Payments for product rights and other, net (404.6) (454.2)
Net cash used in investing activities (639.3) (716.9)
Cash flows from financing activities:    
Payment of financing fees (114.7) (2.4)
Change in short-term borrowings, net (329.7) (75.1)
Proceeds from convertible note hedge 1,970.8 0.0
Proceeds from issuance of long-term debt 2,390.0 635.0
Payment of long-term debt (4,334.1) (695.0)
Proceeds from exercise of stock options 92.8 34.2
Taxes paid related to net share settlement of equity awards (31.7) (22.8)
Payments for contingent consideration 0.0 (150.0)
Acquisition of noncontrolling interest (11.7) 0.0
Other items, net 49.6 22.4
Net cash used in financing activities (318.7) (253.7)
Effect on cash of changes in exchange rates (37.0) (9.3)
Net increase (decrease) in cash and cash equivalents 361.5 (91.7)
Cash and cash equivalents — beginning of period 225.5 291.3
Cash and cash equivalents — end of period $ 587.0 $ 199.6
Non-cash transaction:    
Ordinary shares issued for acquisition 6,305.8 0.0